|
|
||||||||
RESEARCH REPORT |
1 Department of Oral Microbiology, Asahi University School of Dentistry, 1851-1 Hozumi, Mizuho, Gifu 501-0296, Japan; and
2 Shimadzu Techno-Research, Inc., 1 Shimoai-cho, Nishinokyo, Nakagyo-ku, Kyoto 604-8436, Japan;
*corresponding author, tomo527{at}dent.asahi-u.ac.jp
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: dioxins coplanar polychlorinated biphenyls saliva human gingival epithelial cells aryl hydrocarbon receptor
| INTRODUCTION |
|---|
|
|
|---|
Porphyromonas gingivalis, a black-pigmented anaerobic Gram-negative rod, has been associated with the development and progression of periodontal diseases (Slots and Listgarten, 1988), and has been shown to possess short and hairlike structures, fimbriae, on its cell surfaces (Ogawa et al., 1991b). Among the various bacterial cell-surface components, fimbriae are known to be a specific adherent factor in its microbial etiology (Pearce and Buchanan, 1980).
Since approximately 8-10 mg of lipid components were contained in 100 mL of saliva (Slomiany et al., 1982), it is stipulated that lipid-soluble dioxins are included in saliva. In the present study, we examined whether PCBs and PCDDs were measurable in saliva, as well as the influence of these compounds contained in saliva on human gingival epithelial cells (HGEC) and their synergistic effects with P. gingivalis fimbriae.
| MATERIALS & METHODS |
|---|
|
|
|---|
Bacteria and Fimbrial Preparation
Porphyromonas gingivalis strain 381 was grown anaerobically in Gifu anaerobic medium (GAM) broth (Nissui, Tokyo, Japan) supplemented with hemin and menadione for 26 hrs at 37°C. Fimbriae were isolated and purified as described previously (Ogawa et al., 1989). Briefly, bacterial cells were suspended in Tris-buffered saline and gently pipetted, before being agitated. The supernatant obtained by centrifugation was subjected to ammonium sulfate precipitation, and the precipitate was then purified by DEAE-Sepharose column chromatography.
Subjects and Sampling
We collected whole saliva from eight healthy subjects, after receiving informed consent, into a glass bottle that had been washed with toluene followed by acetone. Peripheral blood was obtained from the same healthy subjects and stored in a plastic bag (Terumo, Tokyo, Japan). The study protocols were approved by the Ethical Committee for Clinical Research of Asahi University School of Dentistry.
Sample Clean-up
Approximately 50 g of each saliva specimen was diluted 10-fold in n-hexane-washed water. After the addition of 19 13C12-labeled markers of PCDDs and 22 markers of PCBs as an internal standard (Wellington Laboratories Inc.), the sample solutions were adsorbed onto octadecyl-silica (ODS; 120 Å, 50 µm) for removal of polar lipids and other impurities, and the eluted sample solution was partitioned 3x between dichloromethane and n-hexane-washed water. The concentrated sample extracts were then applied to a multilayered silica gel column (silica, 10% AgNO3/silica, silica, 22% H2SO4/silica, 44% H2SO4/silica, silica, 2% KOH/silica, silica) with hexane used for the mobile phase. Furthermore, clean-up for the PCDD analysis was performed with the use of activated carbon (Wakimoto and Tatsukawa, 1985; Stanley et al., 1988). Lipids in the blood specimens were also extracted, determined gravimetrically, and subjected to a column chromatographic clean-up procedure (Lamparski et al., 1979; Smith et al., 1984).
High-resolution Gas Chromatography (HRGC)/High-resolution Mass Spectrometry (HRMS) Analysis
Samples were concentrated to 30-100 µL after the addition of 4 congeners of 13C12-labeled PCBs and -1,2,3,4-TCDD as a syringe spike, and then the PCBs were analyzed with the use of HRGC (HP6890; Agilent Technologies, Palo Alto, CA, USA)/HRMS (AutoSpec Ultima; Micromass, Manchester, UK) with a DB-5MS column (60 m, 0.32 mm i.d., 0.25-µm film thickness; Agilent Technologies). The following cycle was used: 150°C for 1 min, then 20°C/min up to 185°C, 2°C/min up to 245°C with a three-minute hold, and 6°C/min up to 290°C. PCDD analysis was also performed on a HRGC/HRMS with SP2331 (60 m, 0.32 mm i.d., 0.20-µm film thickness; Supelco, Bellefonte, PA, USA) and DB-17HT (60 m, 0.32 mm i.d., 0.15-µm film thickness, Agilent Technologies) columns. The following cycles were used: 170°C for 3 min, 3°C/min up to 230°C with a three-minute hold, then 3°C/min up to 260°C (SP2331); 150°C for 3 min, 20°C/min up to 200°C, then 3°C/min up to 280°C (DB-17HT). The interface temperature was set 5-10°C higher than the maximum value of each temperature program. Helium was used as the carrier gas, and the electron impact ionization energy was 35-40 eV. The MS was operated in selected ion monitoring mode (SIM) at a resolution of > 10,000 (10% valley). Two predominant ions (M+, M+2, or M+4) were monitored for each congener group.
Cells
Establishment of HGEC has been described previously (Asai et al., 2001). The cells were subsequently maintained in a long-term culture with HuMedia-KG2 (Kurabo Biomedicals, Osaka, Japan). Heparinized venous blood drawn from healthy donors was subjected to fractionation with a Histopaque-1077 (Sigma, St. Louis, MO, USA) used to obtain human peripheral blood mononuclear cells (PBMC). The cells were suspended with RPMI1640 (Sigma) supplemented with 10% FBS (Sigma). The study protocols were approved by the Ethical Committee for Clinical Research of Asahi University School of Dentistry.
RT-PCR Analysis
Total cellular RNA from HGEC and human PBMC was isolated with Trizol (Life Technologies, Rockville, MD, USA), and RNase-free DNase (Takara Biochemicals, Shiga, Japan) was used to remove genomic DNA. Extracted RNA was reverse-transcribed into first-strand cDNA, and PCR amplification of cDNA was performed with oligonucleotide primers specific for aryl hydrocarbon receptor (AhR), 5'-CTTCCAAGCGGCATAGAGAC-3' and 5'-CTACTGTCTGGGGGAGACCA-3'; and ß-actin, 5'-GTGGGGCGCCCCAGGCACCA-3' and 5'-CTCCTTAATGT CACGCACGATTTC-3'.
Cytokine Production
HGEC (1 x 105 cells per well) were seeded in a 24-well flat-bottom microtiter plate (Falcon 3072; Becton Dickinson and Co., Lincoln Park, NJ, USA). After incubation for 16 hrs at 37°C in humidified air containing 5% (v/v) CO2, the monolayers were washed 3 times with PBS (Sigma). The cells were incubated with the indicated doses of test specimen for 24 hrs at 37°C, and then centrifuged at 12,000 x g for 5 min. The production of IL-8 in the culture supernatants was determined by an ELISA. The assays were performed according to the manufacturers instructions (ELISA kit system, Genzyme-Techne, Minneapolis, MN, USA), and results were determined with use of a standard curve prepared for each assay. Data were analyzed by a one-way analysis of variance (ANOVA) with the Bonferroni or Dunn method, and the results are presented as the mean ± standard error of the mean (SEM).
Cytotoxicity
The release of lactate dehydrogenase (LDH) from HGEC was measured in the culture supernatants by means of a colorimetric kit (Roche, Indianapolis, IN, USA) according to the manufacturers instructions. Background control of LDH activity was obtained by measurement of the culture medium. Low control of LDH activity was obtained with the use of culture supernatants released from the untreated cells, and high control of LDH activity was obtained with the use of whole-cell lysates. The percent cytotoxicity was determined according to the following calculation: [(release of LDH from stimulated cells - low control) / (high control - low control)] x 100.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
In periodontal tissues, HGEC have been shown to secrete various cytokines, including IL-8, which attracts and activates neutrophils in the inflammatory lesion (Bickel, 1993; Huang et al., 1998). Further, IL-8 has been shown to be localized in the gingival tissues of patients with periodontal diseases, and IL-8 mRNA levels are known to correspond to the severity of periodontal diseases (Tonetti et al., 1994). In the present study, both PCB 118 and OCDD significantly induced IL-8 production in HGEC under comparable conditions and concentrations in saliva (Fig. 3
).
HGEC and human PBMC constitutively expressed mRNA for AhR as a dioxin receptor (Gonzalez and Fernandez-Salguero, 1998), though the expression in HGEC was weaker (Fig. 2
). In addition, the IL-8-producing activities of HGEC induced by PCB 118 or OCDD were weaker than those of PBMC in a manner that corresponded to the level of AhR mRNA expression (data not shown). These results suggested that AhR in HGEC recognized PCB 118 and OCDD, and that these dioxins induced IL-8 production in saliva, similar to PBMC in blood.
P. gingivalis fimbriae are associated with the adherence of the bacterium to host target cells (Ogawa et al., 1991a). Further, the fimbrial protein possesses various functional properties, including the production of various cytokines in host cells such as human PBMC, gingival fibroblasts, and gingival epithelial cells (Ogawa et al., 1991a, 1997; Asai et al., 2001). These findings suggest that P. gingivalis fimbriae are an important pathogenic factor involved with the inflammation of periodontal tissues seen in patients with periodontal diseases. In the present study, we demonstrated that PCB 118 and OCDD were contained mainly in saliva and clearly augmented IL-8 production in HGEC stimulated with P. gingivalis fimbriae (Fig. 4
). Recently, we demonstrated that P. gingivalis fimbriae activated HGEC and human monocytes through Toll-like receptor (TLR) 2, which is one of the pathogen-associated molecular pattern (PAMP) receptors (Asai et al., 2001; Ogawa et al., 2002). These results suggested that AhR and TLR signaling synergistically augmented IL-8 production in HGEC.
In conclusion, we determined that dioxins in human saliva as well as blood specimens were measurable. Among them, PCB 118 and OCDD were contained predominantly in saliva, and definitely induced IL-8 production in HGEC and augmented IL-8 production induced by P. gingivalis fimbriae. These results indicate that dioxins in saliva may induce a sustained production of pro-inflammatory cytokines in periodontal tissues, and may also be a risk factor for chronic inflammatory diseases including periodontal diseases.
| ACKNOWLEDGMENTS |
|---|
Received April 30, 2003; Last revision July 23, 2003; Accepted July 24, 2003
| REFERENCES |
|---|
|
|
|---|
Ayotte P, Dewailly E, Ryan JJ, Bruneau S, Lebel G (1997). PCBs and dioxin-like compounds in plasma of adult Inuit living in Nunavik (Arctic Quebec). Chemosphere 34:14591468.[Medline]
Bickel M (1993). The role of interleukin-8 in inflammation and mechanisms of regulation. J Periodontol 64:456460.[ISI][Medline]
Clarke DW, Brien JF, Racz WJ, Nakatsu K, Marks GS (1984). The disposition and the liver and thymus gland toxicity of 3,3',4,4'-tetrachlorobiphenyl in the female rat. Can J Physiol Pharmacol 62:12531260.[ISI][Medline]
Elferink CJ, Whitlock JP Jr (1994). Dioxin-dependent, DNA sequence-specific binding of a multiprotein complex containing the Ah receptor. Receptor 4:157173.[ISI][Medline]
Falk C, Hanrahan L, Anderson HA, Kanarek MS, Draheim L, Needham L, et al. (1999). Body burden levels of dioxin, furans, and PCBs among frequent consumers of Great Lakes sport fish. The Great Lakes Consortium. Environ Res 80:S19S25.[Medline]
Gonzalez FJ, Fernandez-Salguero P (1998). The aryl hydrocarbon receptor: studies using the AHR-null mice. Drug Metab Dispos 26:11941198.
Holsapple MP, Morris DL, Wood SC, Snyder NK (1991). 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced changes in immunocompetence: possible mechanisms. Annu Rev Pharmacol Toxicol 31:73100.[ISI][Medline]
Huang GT, Haake SK, Park NH (1998). Gingival epithelial cells increase interleukin-8 secretion in response to Actinobacillus actinomycetemcomitans challenge. J Periodontol 69:11051110.[ISI][Medline]
Iida T, Hirakawa H, Matsueda T, Takenaka S, Nagayama J (1999). Polychlorinated dibenzo-p-dioxins and related compounds: the blood levels of young Japanese women. Chemosphere 38:34973502.[Medline]
Kerkvliet NI (1995). Immunological effects of chlorinated dibenzo-p-dioxins. Environ Health Perspect 103:4753.
Lamparski LL, Nestrick TJ, Stehl RH (1979). Determination of part-per-trillion concentrations of 2,3,7,8-tetrachlorodibenzo-p-dioxin in fish. Anal Chem 51:14531458.[Medline]
McFarland VA, Clarke JU (1989). Environmental occurrence, abundance, and potential toxicity of polychlorinated biphenyl congeners: considerations for a congener-specific analysis. Environ Health Perspect 81:225239.[ISI][Medline]
Ogawa T, Shimauchi H, Hamada S (1989). Mucosal and systemic immune responses in BALB/c mice to Bacteroides gingivalis fimbriae administered orally. Infect Immun 57:34663471.
Ogawa T, Kusumoto Y, Uchida H, Nagashima S, Ogo H, Hamada S (1991a). Immunobiological activities of synthetic peptide segments of fimbrial protein from Porphyromonas gingivalis. Biochem Biophys Res Commun 180:13351341.[ISI][Medline]
Ogawa T, Mukai T, Yasuda K, Shimauchi H, Toda Y, Hamada S (1991b). Distribution and immunochemical specificities of fimbriae of Porphyromonas gingivalis and related bacterial species. Oral Microbiol Immunol 6:332340.[ISI][Medline]
Ogawa T, Ozaki A, Shimauchi H, Uchida H (1997). Hyporesponsiveness of inflamed human gingival fibroblasts from patients with chronic periodontal diseases against cell surface components of Porphyromonas gingivalis. FEMS Immunol Med Microbiol 18:1730.[ISI][Medline]
Ogawa T, Asai Y, Hashimoto M, Uchida H (2002). Bacterial fimbriae activate human peripheral blood monocytes utilizing TLR2, CD14 and CD11a/CD18 as cellular receptors. Eur J Immunol 32:25432550.[ISI][Medline]
Pearce WA, Buchanan TM (1980). Structure and cell membrane-binding properties of bacterial fimbriae. In: Receptors and recognition series B. Vol 6. Bacterial adherence. Beachey EH, editor. London, UK: Chapman & Hall, Ltd., pp. 289-344.
Safe S (1984). Polychlorinated biphenyls (PCBs) and polybrominated biphenyls (PBBs): biochemistry, toxicology and mechanism of action. Crit Rev Toxicol 13:319395.[Medline]
Schecter A, Ryan JJ, Papke O (1994). Elevated dioxin blood levels in Russian chemical workers and their children following maternal exposure. Chemosphere 29:23612370.[Medline]
Slomiany BL, Murty VL, Aono M, Slomiany A, Mandel ID (1982). Lipid composition of human parotid and submandibular saliva from caries-resistant and caries-susceptible adults. Arch Oral Biol 27:803808.[ISI][Medline]
Slots J, Listgarten MA (1988). Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in human periodontal diseases. J Clin Periodontol 15:8593.[ISI][Medline]
Smith LM, Stalling DL, Johnson JL (1984). Determination of part-per-trillion levels of polychlorinated dibenzofurans and dioxins in environmental samples. Anal Chem 56:18301842.[Medline]
Stanley JS, Sack TM, Tondeur Y, Beckert WF (1988). Evaluation of a high-resolution gas chromatography/high-resolution mass spectrometry method for the determination of 2,3,7,8-tetrachlorodibenzo-p-dioxin in soil and water. Biomed Environ Mass Spectrom 17:2735.[Medline]
Svensson BG, Hallberg T, Nilsson A, Schütz A, Hagmar L (1994). Parameters of immunological competence in subjects with high consumption of fish contaminated with persistent organochlorine compounds. Int Arch Occup Environ Health 65:351358.[ISI][Medline]
Tonetti MS, Imboden MA, Gerber L, Lang NP, Laissue J, Mueller C (1994). Localized expression of mRNA for phagocyte-specific chemotactic cytokines in human periodontal infections. Infect Immun 62:40054014.
Van den Berg M, Birnbaum L, Bosveld AT, Brunstrom B, Cook P, Feeley M, et al. (1998). Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ Health Perspect 106:775792.[ISI][Medline]
Wakimoto T, Tatsukawa R (1985). Polychlorinated dibenzo-p-dioxins and dibenzofurans in fly ash and cinders collected from several municipal incinerators in Japan. Environ Health Perspect 59:159162.[ISI][Medline]
This article has been cited by other articles:
![]() |
K. Yoshizawa, N. J. Walker, M. P. Jokinen, A. E. Brix, D. M. Sells, T. Marsh, M. E. Wyde, D. Orzech, J. K. Haseman, and A. Nyska Gingival Carcinogenicity in Female Harlan Sprague-Dawley Rats following Two-Year Oral Treatment with 2,3,7,8-Tetrachlorodibenzo-p-dioxin and Dioxin-Like Compounds Toxicol. Sci., January 1, 2005; 83(1): 64 - 77. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| IADR Journals | Advances in Dental Research ® |
| Journal of Dental Research ® | Critical Reviews (1990-2004) |